Antibiotic resistance crisis: so bad, it's good?
This article was originally published in Scrip
Executive Summary
Around 25,000 people in the EU (including 5,000 children) and 23,000 in the US die each year as a direct result of infections from resistant bacteria, according to estimates by the US Centers for Disease Control and Prevention (CDC) and the European Commission. With the dearth of new antibiotics coming through industry pipelines, it seems likely that these numbers will rise. According to Dr Neil Murray, CEO of Redx Pharma (which has an anti-infectives subsidiary focused on developing new compounds for resistant bacteria), this bad news has a silver lining.